Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 1999, p. 3008-3010, Vol. 43, No. 12
Unité des Agents Antibactériens,
Institut Pasteur, 75724 Paris Cedex 15,1 and
Centre d'Etudes Pharmaceutiques, 92296 Châtenay-Malabry,2 France
Received 12 July 1999/Returned for modification 17 August
1999/Accepted 17 September 1999
The beta-hemolytic group G Streptococcus clinical
isolate BM2721 was resistant to high levels of aminoglycosides by
synthesis of AAC(6')-APH(2"), APH(3')-III, and ANT(6) modifying
enzymes. The corresponding genes were found to be adjacent as the
result of a recombination event between Tn4001 and
Tn5405, two transposons originating in staphylococci.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
High-Level Aminoglycoside Resistance in the
Beta-Hemolytic Group G Streptococcus Isolate
BM2721
*
Corresponding author. Mailing address: Unité des
Agents Antibactériens, Institut Pasteur, 25, rue du Docteur Roux,
75724 Paris Cedex 15, France. Phone: (33) (1) 45 68 83 18. Fax: (33) (1) 45 68 83 19. E-mail: galimand{at}pasteur.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»